Sort by:

select Language:



Integrating the prevention, treatment and care of mental health conditions and other noncommunicable diseases within health systems

World Health Organization WHO, Regional Office for Europe, (2019)


Mental health conditions affect one in 10 people at any one time and account for a large proportion of non-fatal disease burden. There is a high degree of comorbidity between mental health conditions such as depression and other noncommunicable diseases (NCDs), including cardiovascular disease, diabetes and alcohol-use disorders. Mental disorders share common features with other NCDs, including many underlying causes and overarching consequences, their high interdependency and tendency to co-occur, and their predilection to being best managed using integrated approaches.
http://www.euro.who.int/en/health-topics/noncommun...


Other significant mental health complaints: slides

World Health Organization, Eds.: WHO, (2015)


This module aims to provide basic guidance on management of range of mental health complaints not coveredelsewhere in this guide. Some of these complaints may be similar to depression, but upon closer examamination are distinct from the conditions covered in this guide. Other mental health complaints are considered significant when they impair daily functioning or when the person seeks help for them. Other mental health complaints can be due to stress.
https://www.who.int/mental_health/mhgap/trainingma...


Other significant mental health complaints: mhGAP Training of Health-care Providers and training manual, supporting material

World Health Organization, Eds.: WHO, (2015)


OTH supporting material • Role plays • LIVES intervention • Case scenarios • Alternative relaxation exercises • Multiple choice questions • Video link Activity 4: mhGAP OTH module – assessment, management and follow-up
https://www.who.int/mental_health/mhgap/trainingma...


Duration of antipsychotic treatment in individuals with a first psychotic episode

World Health Organization, Eds.: WHO, (2012)


Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
http://www.who.int/mental_health/mhgap/evidence/re...


Recovery-oriented psychosocial strategies enhancing independent living and social skills (such as life skills and social skills training)

World Health Organization, Eds.: WHO, (2015)


Q11. SCOPING QUESTIONS: In people with psychotic disorders (including schizophrenia and bipolar disorder) are recovery-oriented psychosocial strategies enhancing independent living and social skills (such as life skills and social skills training) feasible and effective?
http://www.who.int/mental_health/mhgap/evidence/re...


Psychoses

World Health Organization WHO, (2015)


PSY supporting material • Person stories • Case scenarios • Role plays • Multiple choice questions • Video links
http://www.who.int/mental_health/mhgap/psy_support...


Duration of antipsychotic treatment in individuals with long term and-or recurrent psychotic disorders

World Health Organization WHO, (2012)


Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
https://www.who.int/mental_health/mhgap/evidence/r...


Antipsychotic medications for psychotic disorders

World Health Organization WHO, (2012)


Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
http://www.who.int/mental_health/mhgap/evidence/re...


Combination of two or more antipsychotic medications for psychotic disorders

World Health Organization WHO, (2012)


Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic only?
http://www.who.int/mental_health/mhgap/evidence/re...


Role of anticholinergic medications in patients requiring long-term antipsychotic treatment for psychotic disorders

World Health Organization, Eds.: WHO, (2012)


Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?
https://www.who.int/mental_health/mhgap/evidence/r...


25 hits